This Biotech Has a June 30 FDA Catalyst. A Fund Just Cut Its Stake by $7 Million
17/5 20:52
Key PointsHighVista Strategies sold 238,243 shares of Viridian Therapeutics; the estimated trade size was $7.08 million based on average closing prices from January through March 2026....